IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma With Bronchioloalveolar Carcinoma Subtype

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181abeb5d

Related search